Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +4.65% | +2.27% | -10.00% |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small Molecule Therapeutics
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuichi Iwaki
FOU | Founder | 74 | 00-09-25 |
Jason Kruger
DFI | Director of Finance/CFO | 47 | 22-06-15 |
Kazuko Matsuda
CTO | Chief Tech/Sci/R&D Officer | 58 | 09-12-31 |
David Crean
PRN | Corporate Officer/Principal | 59 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hideki Nagao
BRD | Director/Board Member | 67 | 04-08-31 |
Yuichi Iwaki
FOU | Founder | 74 | 00-09-25 |
Carolyn Beaver
BRD | Director/Board Member | 66 | 20-10-19 |
Kazuko Matsuda
CTO | Chief Tech/Sci/R&D Officer | 58 | 09-12-31 |
Nicole Lemerond
BRD | Director/Board Member | 49 | 23-08-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,046,246 | 47,582,999 ( 97.02 %) | 0 | 97.02 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.00% | 63.27M | |
-1.52% | 104B | |
+6.61% | 97.47B | |
+5.71% | 22.25B | |
-12.95% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.82% | 16.36B | |
+8.13% | 14.39B | |
+37.06% | 12.37B |
- Stock Market
- Equities
- MNOV Stock
- Company MediciNova, Inc.